---

Cardinal Health's Board Of Directors Declares Quarterly Cash Dividend, Announces Ernst & Young As New Independent Auditor, And Appoints Three New Directors To Board

DUBLIN, Ohio, May 8, 2002 - The Board of Directors of Cardinal Health, Inc. (NYSE: CAH) today declared the Company's 71st consecutive regular quarterly dividend. The dividend of $0.025 per common share is payable July 15, 2002, to shareholders of record on July 1, 2002.

Cardinal Health also announced today that its Board of Directors, upon the recommendation of its Audit Committee, has named Ernst & Young LLP as the Company's independent public accountants effective May 9, 2002, succeeding Arthur Andersen LLP.

The appointment of Ernst & Young was made after careful consideration by the Board of Directors, the Audit Committee and the Company's management. The decision to change auditors was not the result of any disagreement between the Company and Arthur Andersen on any matter of accounting principles or practices.

Stated John Finn, Cardinal Health's Audit Committee Chairman, "The decision to change accounting firms was a difficult one and follows a thorough selection process. Ernst & Young is a highly reputable firm with substantial experience serving public companies in the health care sector, and we look forward to working with them in the future. We also want to thank Arthur Andersen for the excellent work provided by their Cardinal Health team."

In addition, Cardinal Health announced the appointment of David W. Raisbeck, Jean G. Spaulding, and Matthew D. Walter to the Company's Board of Directors. The appointments increase the total number of directors from 12 to 15.

David W. Raisbeck, 52, is vice chairman of Cargill, an international marketer, processor and distributor of agricultural, food, financial and industrial products and services with 90,000 employees in 57 countries and fiscal 2001 revenues of $49.4 billion. The company provides distinctive customer solutions in supply chain management, food applications and health and nutrition. Raisbeck has been with Cargill since 1971, during which time the company has dramatically expanded the range of its businesses, providing high-quality, competitively-priced products and services to help farmers and food customers increase their productivity and profitability in basic ingredients used in food production. Cargill has extended its business into the marketing, trading, transporting and processing of a wide range of agricultural and industrial commodities. Cargill's financial business includes proprietary trading activities in global capital markets, investment in real estate and other financial assets. Raisbeck is a board member of Eastman Chemical Company, Horizon Milling, and the Greater Minneapolis YMCA. He also is a member of the Chicago Mercantile Exchange, Minneapolis Grain Exchange and past member of the Chicago Board of Trade and Kansas City Grain Exchange. He holds a B.S. in Industrial Administration from Iowa State University, serves as a governor on the Iowa State University Foundation, and is a member of the dean's advisory council for the School of Business.

Jean G. Spaulding, M.D., 55, is currently a trustee of The Duke Endowment and maintains a private practice in psychiatry for children, adolescents and adults. She holds Associate Clinical Professorships with both the Department of Psychiatry and the Department of Community & Family Medicine at Duke University Medical Center. Dr. Spaulding also serves as an on-camera consultant at WTVD Newschannel 11, the local ABC affiliate in Durham, N.C. She is formerly the Vice Chancellor for Health Affairs, Duke University Medical Center and Health System. Her board memberships include: Wachovia Bank of North Carolina, Josiah Charles Trent Memorial Foundation, and the North Carolina School of the Arts. Dr. Spaulding received an A.B. degree from Barnard College, Columbia University and a doctorate of medicine from Duke University School of Medicine.

Matthew D. Walter, 33, is chief executive officer of Bound Tree Medical, the largest provider of medical equipment and supplies to the emergency medical market in the U.S. He is founding and managing partner of Talisman Capital, a private equity partnership focused on making control-type investments in middle-market companies. His board memberships include Bancinsurance Corp., I KNOW I CAN (a college access program for inner-city children), and The Columbus Academy. He holds a B.A. in Economics from Williams College and an MBA in Entrepreneurial Management from The Wharton School.

"These directors were selected on the basis of their strong credentials and the diversity of leadership and experience they bring to our board," said Robert D. Walter, Cardinal Health chairman and chief executive officer. "Specifically, in addition to David Raisbeck's general management strengths, we are very interested in benefiting from his knowledge and experience in the national and international distribution and trading markets. Jean Spaulding brings a remarkable wealth of experience in medicine, health care systems operations and organizational development, all of which relate directly to our business. Matthew Walter currently owns and operates the largest provider of medical equipment and supplies to the emergency medical market in the U.S., manages a private equity partnership, and has exceptional entrepreneurial and financial acumen. This board expansion will provide additional oversight for the continued significant growth we expect at Cardinal Health over the coming years.

About Cardinal Health

Cardinal Health, Inc. (www.cardinal.com) is the leading provider of products and services supporting the health care industry. Cardinal Health companies develop, manufacture, package and market products for patient care; develop drug-delivery technologies; distribute pharmaceuticals, medical-surgical and laboratory supplies; and offer consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, the company employs more than 49,000 people on five continents and produces annual revenues of more than $40 billion. Cardinal Health is ranked #23 on the current Fortune 500 list and was named one of "The World's Best" companies by Forbes magazine in April 2002.

---

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal Health's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to) the costs, difficulties, and uncertainties related to the integration of acquired businesses, the loss of one or more key customer or supplier relationships, changes in the distribution outsourcing patterns for health-care products and/or services, the costs and other effects of governmental regulation and legal and administrative proceedings, and general economic conditions. Cardinal undertakes no obligation to update or revise any forward-looking statements.